|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
What we’re seeing with Aurora Cannabis and Pareteum Corp.
Therapix Biosciences has potential, but plenty of risks.
We are selling all shares of Nxt-ID and Aurora Cannabis and downgrading Black Box.
The Nasdaq-listed provider of medical marijuana will compete with other firms as Canada opens itself to general adult use of marijuana this fall.
There were several bright spots in the portfolio last week, including Habit Restaurants and USA Technologies.
Kush Bottles rallied 8.2% and Aurora Cannabis soared 18.9% on Constellation Brands’ $4 billion legal-weed investment.
The company seems intriguing, but needs to give us more buzz.
The portfolio had several big winners last week as shares of Habit Restaurants and Energy Recovery soared.
New fund will take a more international focus as more countries move toward legalizing cannabis for medical use.
We trimmed one position and added to another last week as smaller-cap stocks took a hit.
During a week that showed little change for the major stock market indices, the portfolio had a number of outperformers.
Aurora will use Shopify as its e-commerce engine for medical and recreational cannabis distribution globally.
Similar to the Russell 2000 trading off last week so too did a number of our holdings, although there were bright spots as well.
Several micro-cap and private companies are pulling in millions in capital as they prepare for the start of legal adult marijuana use in Canada.
Brian Athaide, formerly the CFO of the company, has been promoted to CEO.
PE-based backers of Canada-based Tilray come from the realm of smart money.
A total of $1.2 billion in debt via 52 transactions was floated by public and private cannabis companies in the six months ended June 29.
The U.S. and China will eventually negotiate, but until then, here is how to play it.
It was a challenging week for the portfolio amid continued trade and tariff concerns.
We will initiate a small spec position in Aurora Cannabis.
With the U.S. and China still "very far apart" in trade talks, and softer-than-expected data from two of the world's biggest economies hinting at a second-quarter slowdown, global stocks are on the back foot Tuesday as investors retrench from recent gains.
Here's what you need to know now for Monday, May 14.
Cannabis stocks are well off their peak valuations hit earlier this year. Expect more deals to happen in the space, and perhaps soon.
Aurora Cannabis Inc. (" Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CanniMed Therapeutics Inc.
We talk with an industry expert about the outlook of the marijuana industry.
Shares of these three companies were big winners following the election last month and have the best long-term growth prospects.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.